OGRMF - Organigram Receives Health Canada Approval for an Additional 17 Cultivation Rooms in Phase 4A

Additional licensed cultivation space brings annual target production capacity to 61,000 kg/yr1

MONCTON, NB, June 24, 2019 /CNW/ – Organigram Holdings Inc. (TSXV:OGI) (OTCQX:OGRMF), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that it has received approval from Health Canada for the licensing of 17 additional cultivation rooms within the Phase 4A/4B perimeter of the building. Thirteen of 31 Phase 4A cultivation rooms originally contemplated have previously been licensed. The 31st room initially contemplated for Phase 4A is being moved from the Company’s 4A ...